Cargando…

Differential effects of sodium-glucose cotransporter 2 inhibitor and low-carbohydrate diet on body composition and metabolic profile in obese diabetic db/db mice

INTRODUCTION: Treatment using sodium-glucose cotransporter (SGLT) 2 inhibitor and low-carbohydrate diet (LCD) for obesity and type 2 diabetes are similar in terms of carbohydrate limitation. However, their mechanisms of action differ, and the effects on the body remain unclear. We investigated the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kusakabe, Toru, Yokota, Shigefumi, Shimizu, Mika, Inoue, Takayuki, Tanaka, Masashi, Ohue-Kitano, Ryuji, Muranaka, Kazuya, Yamakage, Hajime, Wada, Hiromichi, Hasegawa, Koji, Satoh-Asahara, Noriko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473664/ https://www.ncbi.nlm.nih.gov/pubmed/32883687 http://dx.doi.org/10.1136/bmjdrc-2020-001303

Ejemplares similares

A combined index of waist circumference and muscle quality is associated with cardiovascular disease risk factor accumulation in Japanese obese patients: a cross-sectional study
por: Ikeue, Kentaro, et al.
Publicado: (2022)

Prediction of functional profiles of gut microbiota from 16S rRNA metagenomic data provides a more robust evaluation of gut dysbiosis occurring in Japanese type 2 diabetic patients
por: Inoue, Ryo, et al.
Publicado: (2017)

Imatinib Mesylate Reduces Endoplasmic Reticulum Stress and Induces Remission of Diabetes in db/db Mice
por: Han, Myoung Sook, et al.
Publicado: (2009)

Overexpression of lipoic acid synthase gene alleviates diabetic nephropathy of Lepr(db/db) mice
por: Zhao, Yingzheng, et al.
Publicado: (2021)

Oxytocin Suppresses Inflammatory Responses Induced by Lipopolysaccharide through Inhibition of the eIF-2α–ATF4 Pathway in Mouse Microglia
por: Inoue, Takayuki, et al.
Publicado: (2019)

Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial
por: Yamakage, Hajime, et al.
Publicado: (2019)

Early Hepatic Insulin Resistance Precedes the Onset of Diabetes in Obese C57BLKS-db/db Mice
por: Davis, Richard C., et al.
Publicado: (2010)

Pair Feeding, but Not Insulin, Phloridzin, or Rosiglitazone Treatment, Curtails Markers of β-Cell Dedifferentiation in db/db Mice
por: Ishida, Emi, et al.
Publicado: (2017)

Enzamin ameliorates adipose tissue inflammation with impaired adipocytokine expression and insulin resistance in db/db mice
por: Tamura, Yukinori, et al.
Publicado: (2013)

Hyperglycemia and Inflammatory Property of Circulating Monocytes are Associated with Inflammatory Property of Carotid Plaques in Patients Undergoing Carotid Endarterectomy
por: Tanaka, Masashi, et al.
Publicado: (2016)

Fecal microbiota transplantation ameliorates type 2 diabetes via metabolic remodeling of the gut microbiota in db/db mice
por: Chen, Lijuan, et al.
Publicado: (2023)

Beneficial Effects of Ipragliflozin on the Renal Function and Serum Uric Acid Levels in Japanese Patients with Type 2 Diabetes: A Randomized, 12-week, Open-label, Active-controlled Trial
por: Tanaka, Masashi, et al.
Publicado: (2020)

Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 decrease glycemic levels and attenuate diabetes-mediated liver and kidney injury in db/db mice
por: Hsieh, Pei-Shan, et al.
Publicado: (2020)

Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
por: Terami, Naoto, et al.
Publicado: (2014)

Visceral-to-subcutaneous fat ratio is a possible prognostic factor for type 1 endometrial cancer
por: Wada, Michiko, et al.
Publicado: (2021)

Antidiabetic Effects of NRDT50, the Enzyme Composition for Regulating Sugar Metabolism, in Db/db Mice
por: Kim, Daham, et al.
Publicado: (2021)

Association of protein tyrosine phosphatase 1B gene polymorphism with the effects of weight reduction therapy on bodyweight and glycolipid profiles in obese patients
por: Yamakage, Hajime, et al.
Publicado: (2021)

Higher Serum Soluble TREM2 as a Potential Indicative Biomarker for Cognitive Impairment in Inadequately Controlled Type 2 Diabetes Without Obesity: The DOR-KyotoJ-1
por: Tanaka, Masashi, et al.
Publicado: (2022)

Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages
por: Takahashi, Kiyohiko, et al.
Publicado: (2018)

GlycomeDB—a unified database for carbohydrate structures
por: Ranzinger, René, et al.
Publicado: (2011)

The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of foxo1
por: Okamura, Takuro, et al.
Publicado: (2019)

Cosmos DB for MongoDB developers: migrating to Azure Cosmos DB and using the MongoDB API
por: Sharma, Manish
Publicado: (2018)

SAT040 Administration Of A DHCR24 Inhibitor Reduces The Excessive Adrenal Steroidogenesis In db/db Mice Through Effects The Alteration Of Intracellular Cholesterol Metabolism
por: Kamigaki, Risa, et al.
Publicado: (2023)

GlycomeDB – integration of open-access carbohydrate structure databases
por: Ranzinger, René, et al.
Publicado: (2008)

ProCarbDB: a database of carbohydrate-binding proteins
por: Copoiu, Liviu, et al.
Publicado: (2020)

AZP-3404, a Peptide Analog of IGFBP-2, Induces Weight Loss and Improves Glucose Metabolism in Leptin-Resistant db/db Mice
por: Culler, Michael D, et al.
Publicado: (2021)

The effects of dietary instruction on cardiovascular risk markers after smoking cessation: study protocol for a multicenter randomized controlled trial in Japan
por: Komiyama, Maki, et al.
Publicado: (2018)

Psychological Effects of Aromatherapy on Smokers With Depressive Tendencies During Smoking Cessation Treatment: Protocol for a Pre-Post Single-Arm Clinical Trial
por: Hata, Akiko, et al.
Publicado: (2022)

Debuncher DB1 (DB2 and DB3): 1 A06 - 000 - 1
por: Boltezar, E
Publicado: (1970)

Debuncher DB1 (DB2 and DB3): I A06-000-1
por: Boltezar, E
Publicado: (1970)

MultitaskProtDB: a database of multitasking proteins
por: Hernández, Sergio, et al.
Publicado: (2014)

Anti-diabetic activities of catalpol in db/db mice
por: Bao, Qinwen, et al.
Publicado: (2016)

Antidiabetic and Antiobesity Effects of Artemether in db/db Mice
por: Guo, Yu, et al.
Publicado: (2018)

dbCAN3: automated carbohydrate-active enzyme and substrate annotation
por: Zheng, Jinfang, et al.
Publicado: (2023)

Berkeley DB
por: New Riders
Publicado: (2001)

ProteomicsDB
por: Schmidt, Tobias, et al.
Publicado: (2018)

Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db/db Mice
por: Hata, Shinnosuke, et al.
Publicado: (2022)

MongoDB basics : a quick introduction to MongoDB
por: Hows, David, et al.
Publicado: (2014)

Practical MongoDB: architecting, developing, and administering MongoDB
por: Edward, Shakuntala Gupta, et al.
Publicado: (2015)

Segmentation of the Pathophysiological Stages of Diabetic Changes in the db/db Mouse
por: Yamazaki, Masaki, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_d3asm0jbe8qfcd2imuf4b1l7fo